BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15750151)

  • 1. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of 18F-FDG PET in nasopharyngeal carcinoma patients with questionable MRI findings for recurrence.
    Ng SH; Joseph CT; Chan SC; Ko SF; Wang HM; Liao CT; Chang YC; Lin WJ; Fu YK; Yen TC
    J Nucl Med; 2004 Oct; 45(10):1669-76. PubMed ID: 15471831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
    Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
    Yen RF; Hong RL; Tzen KY; Pan MH; Chen TH
    J Nucl Med; 2005 May; 46(5):770-4. PubMed ID: 15872349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.
    Chan SC; Chang JT; Wang HM; Lin CY; Ng SH; Fan KH; Chin SC; Liao CT; Yen TC
    Oral Oncol; 2009 Jan; 45(1):52-8. PubMed ID: 18487079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
    Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of 18F-FDG PET in patients with locoregional advanced nasopharyngeal carcinoma after primary curative therapy: response evaluation and impact on management.
    Chan SC; Yen TC; Ng SH; Lin CY; Wang HM; Liao CT; Fan KH; Chang JT
    J Nucl Med; 2006 Sep; 47(9):1447-54. PubMed ID: 16954552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
    Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
    Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma.
    Liu FY; Lin CY; Chang JT; Ng SH; Chin SC; Wang HM; Liao CT; Chan SC; Yen TC
    J Nucl Med; 2007 Oct; 48(10):1614-9. PubMed ID: 17873135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?
    Yen TC; Chang YC; Chan SC; Chang JT; Hsu CH; Lin KJ; Lin WJ; Fu YK; Ng SH
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):541-8. PubMed ID: 15625603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
    Yu DF; Zuo CT; Dai JZ; Dong MJ; Zhao J; Lin XT; Guan YH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1538-41. PubMed ID: 15566675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of 201TL SPECT/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma.
    Yen RF; Ting LL; Cheng MF; Wu YW; Tzen KY; Hong RL
    Head Neck; 2009 Jun; 31(6):717-24. PubMed ID: 19189341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early restaging whole-body (18)F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yen RF; Chen TH; Ting LL; Tzen KY; Pan MH; Hong RL
    Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1152-9. PubMed ID: 15965687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
    Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
    Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.